Evidence map›Paper›PMID 31735692›Full record

ArticleCurrent problems in pediatric and adolescent health care2019

Gender affirming medical care of transgender youth.

Caroline Salas-Humara, Gina M Sequeira, Wilma Rossi, Cherie Priya Dhar

Open access · greenAbstract read
In one paragraph

Article in Current problems in pediatric and adolescent health care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Gender diversity and cholesterol in early adolescence: Findings from the Adolescent Brain Cognitive Development Study.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  3. Facilitators and Barriers to Research Participation Among Transgender and Gender-Diverse Youth: A Youth-Engaged Qualitative Study.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Article
  11. Clinical pharmacology in adolescent transgender medicine.British journal of clinical pharmacology · 2024
    Review
  12. Review
  13. Article
  14. No Bones About It: Sex Is Binary.Archives of sexual behavior · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Adolescent Providers' Experiences of Harassment Related to Delivering Gender-Affirming Care.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Caroline Salas-HumaraNYU School of Medicine, Department of Pediatrics, Division of Adolescent Medicine, New York, NY, United States. Electronic address: Caroline.Salas-Humara@nyulangone.org.
Gina M SequeiraUPMC Children's Hospital of Pittsburgh, Center for Adolescent and Young Adult Health, United States.
Wilma RossiChildren's Hospital of Philadelphia, United States.
Cherie Priya DharAnn & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, United States.
Children's Hospital of Philadelphia · USChildren's Hospital of Pittsburgh · USLurie Children's Hospital · US

Funding

Adolescent Research in Community Postdoctoral Training ProgramT32HD087162 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MILLER, ELIZABETH · 2016 to 2020
$1.2M
NICHD NIH HHS T32 HD087162
6 · The paper itself

Abstract

The number of gender diverse and transgender youth presenting for treatment are increasing. This is a vulnerable population with unique medical needs; it is essential that all pediatricians attain an adequate level of knowledge and comfort caring for these youth so that their health outcomes may be improved. There are several organizations which provide clinical practice guidelines for the treatment of transgender youth including the WPATH and the Endocrine Society and they recommend that certain eligibility criteria should be met prior to initiation of gender affirming hormones. Medical intervention for transgender youth can be broken down into stages based on pubertal development: pre-pubertal, pubertal and post-pubertal. Pre-pubertally no medical intervention is recommended. Once puberty has commenced, youth are eligible for puberty blockers; and post-pubertally, youth are eligible for feminizing and masculinizing hormone regimens. Treatment with gonadotropin releasing hormone agonists are used to block puberty. Their function is many-fold: to pause puberty so that the youth may explore their gender identity, to delay the development of (irreversible) secondary sex characteristics, and to obviate the need for future gender affirmation surgeries. Masculinizing hormone regimens consists of testosterone and feminizing hormone regimens consist of both estradiol as well as spironolactone. In short term studies gender affirming hormone treatment with both estradiol and testosterone has been found to be safe and improve mental health and quality of life outcomes; additional long term studies are needed to further elucidate the implications of gender affirming hormones on physical and mental health in transgender patients. There are a variety of surgeries that transgender individuals may desire in order to affirm their gender identity; it is important for providers to understand that desire for medical interventions is variable among persons and that a discussion about individual desires for surgical options is recommended.

Indexed as

Delivery of Health CarePhysician-Patient RelationsDrug CostsFemaleGender-Affirming SurgeryHormonesHumansMaleMass ScreeningTransgender PersonsHormones

Identifiers

PMID31735692
PMCPMC8496167
OpenAlexW2988355138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.